Cardiovate 20logo 20square

Cardiovate Inc.

Cardiovate is developing an implantable device to repair vascular abnormalities by facilitating organized new tissue growth from a patient's own cells.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location San Antonio, TX, USA
  • Currency USD
  • Founded March 2012
  • Employees 3
  • Website

Company Summary

Cardiovate is a medical technology company that targets transformational health care opportunities in tissue regeneration and repair through the development of novel products that utilize proprietary materials and processes along with a deep understanding of clinical needs. The Cardiovate scaffold promotes the patient’s own cells to organize into a viable tissue after implantation for repair or replacement of damaged and diseased vasculature.


  • 04a7aeea d8b6 40d6 b937 b89ddde940c6
    Chief Technology Officer, Director

    Jordan Kaufmann, PhD. is a co-founder of Cardiovate and currently serves as the company’s President and CTO. Dr. Kaufmann has spent 6 years developing the technology behind Cardiovate and is the lead inventor on the patents. She holds unique experience in the technology’s manufacturing process, benefits, and limitations. Dr. Kaufmann specializes in biomaterials for medical devices and product development.

  • B638c7ee 95d6 4afa a4b8 6be20bc05c94
    Advisory Board Member

    Dr. Niederauer currently acts as an advisor to Cardiovate. She has over 20 years of medical startup experience with 3 successful biotech companies to date. She has extensive experience in taking medical devices from concept to market including the FDA regulatory process expertise. She also brings to Cardiovate extensive connections to the medical device industry and investor networks.

  • Bc32d0a8 08ce 4a97 aac8 b966c679edb2
    Chief Financial Officer

    Mark Horsey, MBA, is a results-oriented, operational and financial leader. He has extensive knowledge of start-up finance and operations in addition to over 15 years of broad international and domestic experience building financial infrastructure for multi-national corporations in the biotech, information technology, and retail fields. Mark is known for providing high quality analytics to drive informed business decisions.

  • Default avatar
    Mauli Agrawal
    Chairman of the Board

    Mauli Agrawal, Ph.D., a co-founder of Cardiovate, is the interim Vice President for Research at the University of Texas at San Antonio. As an expert in biomaterials he has started 3 biomedical companies in San Antonio including Xilas Medical (later Diabetica Solutions) of which he was the CEO during its early phase. He has strong connections with the investor community in Texas and direct experience with medical device startups.

  • Default avatar
    Steven Bailey

    Steven Bailey, M.D., a co-founder of Cardiovate, is the Chief of the Department of Cardiology at UTHSCSA. He specializes in interventional cardiology and is considered to be among the top 1% of cardiologists in the US. Dr. Bailey serves as the Director of the Janey Briscoe Center of Excellence in Cardiovascular Research. Dr. Bailey has played an integral role in a number of medical device companies and holds several patents in the field.

  • Ba4beb78 20ce 4fa6 ab20 355765451a7e
    Chief Executive Officer, Director

    Mr. Standeford has over 25 years of experience in medical device development. His leadership in strategic marketing, R&D, LM&A and commercialization has generated significant value to patients, clinicians and companies. He has also been a partner in two start-up business ventures and has served as a commissioner for the city of San Antonio. He holds an Executive MBA and is a certified Project Management Professional.


  • Default avatar
    Jackson Walker

Previous Investors

  • Default avatar
    UT Horizon Fund